Transformational Science that Transforms Lives
Immunocore is a leading T cell receptor (TCR) company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, through its pioneering soluble TCR technology platform. The scientific expertise at Immunocore spans the entire process of drug development. From the discovery and validation of suitable disease targets, through to the design and engineering of immune-activating TCR-based reagents, and preclinical and clinical assessment.
Apr 01, 2018 Immunocore Publishes Gender Pay Report
Feb 08, 2018 Immunocore Announces Leadership Change